Skip to content

Effects of Upper Extremity Rehabilitation Using Smart Glove in Stroke Patients

Effects of Upper Extremity Rehabilitation Using Smart Glove in Stroke

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02592759
Enrollment
23
Registered
2015-10-30
Start date
2015-10-31
Completion date
2018-12-31
Last updated
2019-10-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hemiplegia, Stroke

Brief summary

The purpose of this study is to evaluate the therapeutic effects of smart glove which is motion-based program designed for upper extremity rehabilitation after stroke.

Detailed description

This study will evaluate the therapeutic effects (upper extremity power, function and activity of daily living) of smart glove which is motion-based rehabilitation program.

Interventions

DEVICESmart Glove Treatment

Smart glove is digital motion-based treatment device for stroke rehabilitation. The stroke patients wear this glove and hand motion is displayed on the computer monitor. They play games with this glove and are motivated to rehabilitation treatment because of fun.

Sponsors

SMG-SNU Boramae Medical Center
CollaboratorOTHER
Seoul National University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
19 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* CT or MRI proved 1st stroke patients with unilateral hemiplegia caused by stroke (ischemic, hemorrhagic, intracranial hemorrhage) * 72 hours \ 3 months after stroke * Upper extremity hemiplegia with Brunnström stage 2-5. * The patients can sit to receive treatment for at least 1 hour

Exclusion criteria

* The patients cannot perform occupational treatments because of severe hemineglect or hemianopia * Contracture due to severe limitation of motion * Upper extremity spasticity in the wrist and fingers with modified Ashworth scale \> 2 points * Fugl-Meyer Assessment-Wrist & Hand score \>= 21 points * moderate to severe cognitive dysfunction \< MMSE 18 points * Severe aphasia * The patients who has been diagnosed as malignant tumor

Design outcomes

Primary

MeasureTime frameDescription
Fugl-Meyer Assessment of Upper Extremity changeChange from baseline points at 2 weeks and 6 weeksEvaluation tool for upper extremity function

Secondary

MeasureTime frameDescription
Modified Barthel Index changeChange from baseline points at 2 weeks and 6 weeksEvaluation tool for the level of active daily living
Care Burden Scale changeChange from baseline points at 2 weeks and 6 weeksEvaluation tool to measure the care burden
Brunnström stage changeChange from baseline stage at 2 weeks and 6 weeksEvaluation tool for recovery
Jebsen Hand function Test changeChange from baseline points at 2 weeks and 6 weeksEvaluation tool for upper extremity function
Box and Block Test changeChange from baseline points at 2 weeks and 6 weeksEvaluation tool for upper extremity function
Hand power changeChange from baseline power at 2 weeks and 6 weeksHand power using hand-held dynamometer

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 17, 2026